Kenvue Inc

Johnson & Johnson tops quarterly profit estimates as medical device sales jump
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business surged. Meanwhile, the company’s total revenue for the […]
Read More
4 cheap stocks to acquire and maintain for the upcoming ten years, according to the professionals
Several shares search pricey in present day industry, but there are still low-cost shares to be discovered — some of which can be held for the next 10 yrs, in accordance to the execs. They shared with CNBC Pro their recommendations for finding low cost stocks that hold very long-term assure, as perfectly as their […]
Read More
Shares producing the major premarket moves: Nike, CarMax, Robinhood, Alpine Immune Sciences and additional
Check out the organizations generating the most important moves in premarket buying and selling: CarMax — Shares sank 9% following the applied-car retailer documented an earnings and profits skip for its fourth quarter. CarMax’s earnings came in at 32 cents for each share, as opposed to the 49 cents predicted from analysts polled by LSEG. […]
Read More
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical and medical devices businesses surged. J&J also provided full-year […]
Read More
CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves
Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023. Joe Raedle | Getty Images CVS is removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday. The company’s decision comes […]
Read More
Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported adjusted earnings and revenue that topped Wall Street’s expectations, driven by a surge in sales in the company’s medical devices and pharmaceutical business divisions. […]
Read More
Birkenstock expects to price IPO at $46 per share, toward midpoint of stated range
Birkenstock models stand in a retail store of the shoe manufacturer. The company plans to go public in New York. Sebastian Christoph Gollnow | Picture Alliance | Getty Images Birkenstock, the longtime German shoe brand known for its comfy and durable styles, is expected to price its IPO at $46 per share on Tuesday, giving […]
Read More
After Birkenstock’s ‘Barbie’ bump, iconic footwear brand seeks a big part in IPO market
Nordstrom department store display of Birkenstock sandals at the Shops at Merrick Park, Miami. Jeff Greenberg | Universal Images Group | Getty Images Birkenstock, the iconic footwear company that dates back to the 18th century, made official on Tuesday what’s been rumored in the press for months: it is planning an initial public offering. The […]
Read More
Decongestant found in many cold, allergy medicines doesn’t actually work, FDA advisors say
A combination package of Procter & Gamble Co. DayQuil Severe and NyQuil Severe brand cold and flu medicine is arranged for a photograph in Tiskilwa, Illinois. Daniel Acker | Bloomberg | Getty Images The main ingredient used in many popular over-the-counter cold and allergy medications doesn’t actually work to get rid of nasal congestion, an […]
Read More
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
Kenvue, a unit of Johnson & Johnson’s consumer health business. CFOTO | Future Publishing | Getty Images Johnson & Johnson on Monday said it plans to reduce by at least 80% its stake in Kenvue, the consumer health business it spun out as an independent company earlier this year, via a stock exchange offer. J&J […]
Read More